Intraventricular treatment of secondary central nervous system lymphoma – Case study and literature overview

Publication date: May–June 2018Source: Neurologia i Neurochirurgia Polska, Volume 52, Issue 3Author(s): Dariusz Szczepanek, Ewa Wąsik-Szczepanek, Agnieszka Szymczyk, Tomasz Gromek, Ewelina Grywalska, Monika Podhorecka, Marek HusAbstractSecondary nervous system lymphoma (SCNSL) is a rare extranodal form of non-Hodgkin lymphoma (NHL). This applies to a particular form of lymphoma that does not originally derive from the central nervous system (CNS); it can be both an isolated form of relapse or a systemic part of disease progression. Due to poor prognosis and a lack of established algorithms of therapeutic procedures, it is a big challenge for physicians from many specializations. In our study, we present an interesting case of a patient with a relapsed form of SCNSL for whom a unique form of treatment was used – intraventricular administration of rituximab and methotrexate.
Source: Polish Journal of Neurology and Neurosurgery - Category: Neurosurgery Source Type: research